Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Italian study backs neonatal ECG screening:

This article was originally published in Clinica

Executive Summary

In what supports the implementation of neonatal ECG screening programmes, an Italian study of over 21,000 newborns has found that an ECG performed in the first month of life identifies abnormalities associated with risk of cardiovascular disease and death. Neonatal ECG can also prompt early identification of still asymptomatic infants with cardiovascular malformations, thus allowing therapeutic interventions, including surgery, before the development of irreversible or serious cardiac damage, said the researchers, led by Marco Stramba-Badiale, of the IRCCS Instituto Auxologico Italiano, in Milan. The study was presented this month at the American Heart Association meeting, in New Orleans.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060331

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel